中国医药导报
中國醫藥導報
중국의약도보
CHINA MEDICAL HERALD
2014年
21期
4-7
,共4页
徐磊%刘文龙%王志超%乔忠杰
徐磊%劉文龍%王誌超%喬忠傑
서뢰%류문룡%왕지초%교충걸
阴茎癌%平阳霉素%新辅助化疗%免疫组织化学法
陰莖癌%平暘黴素%新輔助化療%免疫組織化學法
음경암%평양매소%신보조화료%면역조직화학법
Penile cancer%Pingyangmycin%Neoajuvant chemotherapy%Immunohistochemistry
目的:探讨应用平阳霉素新辅助化疗对阴茎癌组织基因蛋白c-myc、Ras-P21、P53表达的影响及意义。方法收集哈尔滨医科大学附属肿瘤医院泌尿外科1995~2005年罹患阴茎鳞状细胞癌的住院患者100例,按照术前是否进行辅助化疗分为两组,其中新辅助化疗组50例,术前应用平阳霉素化疗7 d,化疗后行阴茎部分切除术,并行双侧腹股沟淋巴结改良清扫术;对照组50例,直接行手术治疗(手术治疗方法同新辅助化疗组),术前不进行化学药物治疗。应用免疫组织化学法(SP)对两组患者的阴茎鳞状细胞癌组织进行c-myc、Ras-P21以及P53等指标检测。结果新辅助化疗组组织标本中c-myc、Ras-P21、P53等指标表达的阳性率经检测分别为30豫、27豫、23豫。对照组组织标本中,c-myc、Ras-P21、P53等指标表达的阳性率经检测分别为52豫、48豫、50豫。新辅助化疗组与对照组的c-myc、Ras-P21、P53指标表达阳性率比较,差异有统计学意义(P<0.05)。结论应用平阳霉素新辅助化疗后,阴茎鳞状细胞癌组织中c-myc、Ras-P21、P53蛋白的表达明显下降,平阳霉素新辅助化疗可降低阴茎癌的恶性程度。
目的:探討應用平暘黴素新輔助化療對陰莖癌組織基因蛋白c-myc、Ras-P21、P53錶達的影響及意義。方法收集哈爾濱醫科大學附屬腫瘤醫院泌尿外科1995~2005年罹患陰莖鱗狀細胞癌的住院患者100例,按照術前是否進行輔助化療分為兩組,其中新輔助化療組50例,術前應用平暘黴素化療7 d,化療後行陰莖部分切除術,併行雙側腹股溝淋巴結改良清掃術;對照組50例,直接行手術治療(手術治療方法同新輔助化療組),術前不進行化學藥物治療。應用免疫組織化學法(SP)對兩組患者的陰莖鱗狀細胞癌組織進行c-myc、Ras-P21以及P53等指標檢測。結果新輔助化療組組織標本中c-myc、Ras-P21、P53等指標錶達的暘性率經檢測分彆為30豫、27豫、23豫。對照組組織標本中,c-myc、Ras-P21、P53等指標錶達的暘性率經檢測分彆為52豫、48豫、50豫。新輔助化療組與對照組的c-myc、Ras-P21、P53指標錶達暘性率比較,差異有統計學意義(P<0.05)。結論應用平暘黴素新輔助化療後,陰莖鱗狀細胞癌組織中c-myc、Ras-P21、P53蛋白的錶達明顯下降,平暘黴素新輔助化療可降低陰莖癌的噁性程度。
목적:탐토응용평양매소신보조화료대음경암조직기인단백c-myc、Ras-P21、P53표체적영향급의의。방법수집합이빈의과대학부속종류의원비뇨외과1995~2005년리환음경린상세포암적주원환자100례,안조술전시부진행보조화료분위량조,기중신보조화료조50례,술전응용평양매소화료7 d,화료후행음경부분절제술,병행쌍측복고구림파결개량청소술;대조조50례,직접행수술치료(수술치료방법동신보조화료조),술전불진행화학약물치료。응용면역조직화학법(SP)대량조환자적음경린상세포암조직진행c-myc、Ras-P21이급P53등지표검측。결과신보조화료조조직표본중c-myc、Ras-P21、P53등지표표체적양성솔경검측분별위30예、27예、23예。대조조조직표본중,c-myc、Ras-P21、P53등지표표체적양성솔경검측분별위52예、48예、50예。신보조화료조여대조조적c-myc、Ras-P21、P53지표표체양성솔비교,차이유통계학의의(P<0.05)。결론응용평양매소신보조화료후,음경린상세포암조직중c-myc、Ras-P21、P53단백적표체명현하강,평양매소신보조화료가강저음경암적악성정도。
Objective To evaluate the influence and significance of Pingyangmycin neoajuvant chemotherapy on the c-myc, Ras-P21 and P53 protein expression in penile cancer on. Methods The Data of 100 patiens with penile squamous cell carcinoma were obtained in the Department of Urology, the Tumor Hospital of Harbin Medical University, from 1995 to 2005, and they were divided into two groups according to whether given the neoajuvant chemotherapy before the surgery or not. 50 patients in the neoajuvant group were given Pingyangmycin preoperative chemotherapy for 7 days before surgery, after the chemotherapy, partial excision of penis plus improved inguinal lymph node dissection was per-formed. 50 patients in the control group were given partial excision of penis plus improved inguinal lymph node dissec-tion directly without any pre-operative chemotherapy. All pathology specimens were detected of c-myc, Ras-P21, P53 protein product expression by immunohistochemical staining assay. Results In neoajuvant chemotherapy group, the pos-itive expression rates of c-myc, Ras-P21, P53 were 30%, 27%, 23%,respectively. While in control group, the positive expression rates of c-myc, Ras-P21, P53 were 52%, 48%, 50%, the differences were statistically significant (P<0.05). Conclusion The c-myc, Ras-P21, P53 protein expressions are significantly decreased in the tissue of Pingyangmycin neoajuvant chemotherapy of penile cancer, Pingyangmycin neoajuvant chemotherapy may decrease the degree of malig-nancy of penile cancer.